BAYER (BAYER) News
Follow BAYER (BAYER) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Bayer raises annual profit forecast as pharma beats Q3 expectations
Bayer raised its annual profit forecast, while its pharmaceutical division exceeded expectations in the third quarter.
EQUITY | Nov 03, 2026, 07:30 AM UTC
M
Bayer raises full-year targets, CEO sees turning point
Bayer raised its full-year targets, with its CEO describing the company as at a “turning point.”
EARNINGS | Nov 03, 2026, 07:10 AM UTC
M
Bayer Raises 2026 Profit Outlook
EARNINGS | Nov 03, 2026, 06:57 AM UTC
M
Bayer Q3 Sales Rise as Pharmaceuticals Growth Lifts Outlook
EARNINGS | Nov 03, 2026, 06:41 AM UTC
H
Bayer Q3 26 Earnings
Sales: 10.05B (est 9.89B) Adj EBITDA: 1.62B (est 1.42B) Adj EBITDA Margin: 16.1% (est 14.2%) Sees FY Adj EBITDA: 9.8B To 10.3B (est 9.82B) Sees FY Negative Free Cash Flow: 500M To 1.5B (est Negative 1.61B)
EARNINGS | Nov 03, 2026, 06:41 AM UTC
M
Bayer raises 2026 Pharmaceuticals EBITDA margin outlook
Bayer raised its expected 2026 EBITDA margin before special items for its Pharmaceuticals division to a range of 25 to 27 VH, citing business development.
EARNINGS | Nov 03, 2026, 06:36 AM UTC
M
Bayer Reports Group Loss Amid Extraordinary Impairments
Bayer reported a negative group result, citing extraordinary impairments at Pharmaceuticals and Consumer Health.
EARNINGS | Nov 03, 2026, 06:33 AM UTC
M
Bayer Reports Q3 Adjusted EBITDA of EUR 1,615 Million
EARNINGS | Nov 03, 2026, 06:32 AM UTC
M
Bayer Reports Q3 EBIT of EUR -110 Million
EARNINGS | Nov 03, 2026, 06:32 AM UTC